EPIC: At the forefront of biomedical research on eukaryotic pathogens
EPIC: At the forefront of biomedical research on eukaryotic pathogens
Clemson University’s Eukaryotic Pathogens Innovation Center — EPIC — is an interdisciplinary research cooperative founded in 2013 that is at the forefront of biomedical research on these devastating pathogens.
EPIC scientists have a lengthy track record of major contributions in this globally important area of research.
EPIC is hiring! For more information and to apply, click here.
Congratulations to Dr. Kozubowski on his two recent grants!
Dr. Lukasz Kozubowski (co-PI) in collaboration with Dr. Julia Brumaghim from the Department of Chemistry (PI) received an NSF award of $492k split between their two laboratories to study the mechanisms that lead to the development of resistance to azole drugs in Cryptococcus neoformans.
Project Name: Azole Antifungals Coordinate Metals and Create Reactive Oxygen Species That Damage DNA and Cause Chromosomal Instability
Project Number: Award Number (FAIN): 2203847
https://nsf.gov/awardsearch/showAward?AWD_ID=2203847&HistoricalAwards=false
The National Institute Of Allergy And Infectious Diseases awarded Dr. Lukasz Kozubowski a five-year grant of ~$1.9 total amount for 5 years to focus on a fungal infection associated with HIV/AIDS. The study will help to identify safer and more effective drugs that target cryptococcal infections like the life-threatening meningo-encephalitis in an immunocompromised host.
Project Name: The role of septins in the adaptation of Cryptococcus neoformans to host temperature in HIV-based cryptococcosis
Project Number: 1R01AI167692-01A1
https://reporter.nih.gov/search/CJzvGnP_kESu4MZKOQ4Zmw/project-details/10619216
Questions?
For further information about the EPIC please contact us.